Muscle wasting disease: A proposal for a new disease classification

Journal of Cachexia, Sarcopenia and Muscle

Volumn 5, Issue 1, 2014, Pages 1-3

  Anker, Stefan D ^a,b   Coats, Andrew J S ^c,d   Morley, John E ^e   Rosano, Giuseppe ^f   Bernabei, Roberto ^g   von Haehling, Stephan ^a   Kalantar Zadeh, Kamyar ^h  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f IRCCS SAN RAFFAELE PISANA   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cachexia; Definition; Muscle wasting disease; Sarcopenia; Treatment development

Indexed keywords

ACTIVIN RECEPTOR; GHRELIN; MYOSTATIN; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SOMATOMEDIN C;

AGING; ATTITUDE TO ILLNESS; CACHEXIA; CHRONIC DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MEDICAL EDUCATION; MUSCLE ATROPHY; MYOPENIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SARCOPENIA; WASTING SYNDROME;

EID: 84894630435     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-014-0135-0     Document Type: Review

References (13)

1. von Haehling S, Morley JE, Anker SD. From muscle wasting to sarcopenia and myopenia: update 2012. J Cachexia Sarcopenia Muscle. 2012;3: 213-7.
2. von Haehling S, Anker SD. Cachexia vs obesity: where is the real unmet clinical need. J Cachexia Sarcopenia Muscle. 2013;4: 245-6.
3. Farkas J, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M. Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle. 2013;4: 173-8.
4. Kalantar-Zadeh K, Rhee C, Sim JJ, Stenvinkel P, Anker SD, Kovesdy CP. Why cachexia kills: examining the causality of poor outcomes in wasting conditions. J Cachexia Sarcopenia Muscle. 2013;4: 89-94.
5. Abstracts of the 7th cachexia conference, Kobe/Osaka, Japan, December 9-11, 2013. J Cachexia Sarcopenia Muscle. 2013;4:(4)295-343.
6. Vaughan VC, Martin P, Lewandowski PA. Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle. 2013;4: 95-109.
7. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008;27: 793-9.
8. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12: 489-95.
9. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and nutrition in geriatrics". Clin Nutr. 2010;29: 154-9.
10. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, et al. Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12: 403-9.
11. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12: 249-56.
12. Fearon K, Evans WJ, Anker SD. Myopenia-a new universal term for muscle wasting. J Cachexia Sarcopenia Muscle. 2011;2: 1-3.
13. Inui A. An invitation to the 7th Cachexia Conference, Kobe, Japan. J Cachexia Sarcopenia Muscle. 2013;4: 171.